Environ Sci Ecotechnol
October 2021
The road transport sector in megacities is confronted with pressing local air pollution and carbon dioxide (CO) control issues. To determine effective policy instruments for saving energy and the co-control of air pollutants and CO, several mainstream measures were examined and compared in Chongqing's road transport sector from 2017 to 2035. An integration assessment framework was developed by combining the Long-range Energy Alternatives Planning (LEAP) system and a set of quantitative methods for evaluating the co-benefits of emission reductions (including the air pollutant equivalent (AP), co-control coordinate system, and pollutant reduction cross-elasticity (Els)).
View Article and Find Full Text PDFIn order to further improve the accuracy of fine particulate matter (PM) source apportionment results, a hybrid source apportionment approach (CTM-RM) combining the capabilities of a receptor model (RM) and chemical transport model (CTM) was developed. The CTM-RM method was evaluated and applied according to a typical PM pollution process from January 21 to 27, 2019 in Chongqing. The average value of square prediction error based on CTM-RM was 84.
View Article and Find Full Text PDFBackground: Castration-resistant prostate cancer (CRPC) with sustained androgen receptor (AR) signaling remains a critical clinical challenge, despite androgen depletion therapy. The Jumonji C-containing histone lysine demethylase family 4 (KDM4) members, KDM4A‒KDM4C, serve as critical coactivators of AR to promote tumor growth in prostate cancer and are candidate therapeutic targets to overcome AR mutations/alterations-mediated resistance in CRPC.
Methods: In this study, using a structure-based approach, we identified a natural product, myricetin, able to block the demethylation of histone 3 lysine 9 trimethylation by KDM4 members and evaluated its effects on CRPC.
Based on the basic information of the Second National Pollution Source Census and the VOCs source profiles of industrial industries, we established the speciated emission inventory of major industrial sources in Chongqing in 2017, estimated their ozone formation potential (OFP), and identified the key control species of industrial VOCs and their sources. The results showed that the total VOCs emission from industrial sources and their OFPs were 144.12 kt and 477.
View Article and Find Full Text PDFIn late August 2020, a period of O pollution occurred in the main urban area of Chongqing and lasted for approximately 2 weeks (till early September). Ambient air samples, collected using Summa Canisters and DNPH sampling columns at three observation sites in the main urban area, were used to study the composition, photochemical reaction activity, and source apportionment of volatile organic compounds (VOCs) during the period of O pollution. The results showed that the mean volume fraction of TVOCs in the main urban area of Chongqing during the observation period was 45.
View Article and Find Full Text PDFMicroRNAs (miRNAs) diagnostics can be useful for diagnosing or confirming miRNA abundance and are used in screening tests and to assess changes in miRNAs in vivo. At present, the use of traditional nucleic acid amplification assays to detect miRNAs has been limited in laboratory environment because of the time, equipment, and technical expertise required to perform these assays. A specialized, rapid affordable miRNA detection system is necessary when there are limited resources or point-of-care testing needs.
View Article and Find Full Text PDFPM2.5 was sampled from commercial, industrial and residential areas in Chongqing urban city from 2nd May to 10th May 2012 in order to find out characteristics and sources of carbon in PM2.5.
View Article and Find Full Text PDFA number of pharmacologic treatments examined in recent randomized clinical trials (RCTs) have failed to show statistically significant superiority to placebo in conditions in which their efficacy had previously been demonstrated. Assuming the validity of previous evidence of efficacy and the comparability of the patients and outcome measures in these studies, such results may be a consequence of limitations in the ability of these RCTs to demonstrate the benefits of efficacious analgesic treatments vs placebo ("assay sensitivity"). Efforts to improve the assay sensitivity of analgesic trials could reduce the rate of falsely negative trials of efficacious medications and improve the efficiency of analgesic drug development.
View Article and Find Full Text PDF